Search Within

Meighan Maye Gallagher

Formats
  1. Meeting Abstract (23)
  2. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (17)
  2. Department of Medicine (16)
  3. GSK Faculty (15)
  4. Human Oncology and Pathogenesis Program (15)
  5. Department of Pathology and Laboratory Medicine (14)
  6. Hematologic Malignancies Research (14)

More Groups

People
  1. Katharine Hsu (13)
  2. Jeffrey Catalano (6)
  3. Lee Tan (6)
  4. Niamh Conlon (6)
  5. Adriana Dionigi Corben (5)
  6. Jeffrey Venstrom (5)

More People

Years
  1. 2016 (1)
  2. 2015 (4)
  3. 2014 (11)
  4. 2013 (2)
  5. 2012 (6)
  6. 2011 (4)
Publications
  1. Laboratory Investigation (5)
  2. Modern Pathology (5)
  3. Biology of Blood and Marrow Transplantation (4)
  4. Blood (4)
  5. Pediatric Blood and Cancer (3)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. Nature Publishing Group (6)
  2. Nature Research (5)
  3. American Society of Hematology (4)
  4. Elsevier Inc. (4)
  5. Wiley Periodicals, Inc (3)
  6. American Association for Cancer Research (1)

More Publishers

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1
    Journal Article

    Venstrom, J. M.; Pittari, G.; Gooley, T. A.; Chewning, J. H.; Spellman, S.; Haagenson, M.; Gallagher, M. M.; Malkki, M.; Petersdorf, E.; Dupont, B.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Journal Article

    Tarek, N.; Luduec, J. B. L.; Gallagher, M. M.; Zheng, J.; Venstrom, J. M.; Chamberlain, E.; Modak, S.; Heller, G.; Dupont, B.; Cheung, N. K. V.; more...
    Journal of Clinical Investigation (2012)

    Fulltext@MSK | Save
  • KIR3DL1/S1 and HLA-B alleles combine to influence unrelated hematopoietic stem cell transplantation (HSCT) outcomes
    Meeting Abstract

    Giglio, F.; Venstrom, J. M.; Gooley, T. A.; Gallagher, M. M.; Lebedeva, T.; Noreen, H.; Rajalingam, R.; Reed, E. F.; Vierra-Green, C.; Yu, N.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Donor kir2ds1 and kir3ds1 are associated with improved outcomes following unrelated allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Venstrom, J. M.; Pittari, G.; Chewning, J.; Gooley, T. A.; Spellman, S.; Haagenson, M.; Gallagher, M. M.; Malkki, M.; Petersdorf, E.; Dupont, B.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • KIR-HLA genotypes have no identifiable role in unit predominance following double unit cord blood transplantation
    Meeting Abstract

    Tarek, N.; Gallagher, M. M.; Chou, J. F.; Lubin, M. N.; Heller, G.; Barker, J. N.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Normally hyporesponsive unlicensed natural killer cells are stronglyactivated by neuroblastoma (Nb) in the presence of anti-gd2 monoclonal antibody (MoAb)
    Meeting Abstract

    Tarek, N.; Gallagher, M.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save